STAAR Surgical shareholders vote down Alcon merger; deal terminated

STAAR SURGICAL CO

Preliminary vote tally failed to secure enough shareholder approval for the Alcon merger at special meeting on Jan 6, 2026.
STAAR will terminate the merger agreement with Alcon; no termination fee payable by either party.
Company remains standalone publicly traded (STAA); CEO Stephen Farrell highlights focus on EVO ICL technology and profitable growth.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.